NewsRoom Articles - Page 6 of 154 - PsychedelicNewsWire (PNW)

MondayNov 11, 2024 2:30 pm

Massachusetts Voters Say No to Measure Seeking to Decriminalize Psychedelics

Voters in the state of Massachusetts have rejected a ballot measure that would’ve removed penalties for the sharing, possession, and non-commercial production of a range of naturally occurring psychedelics. Results from the election night show that 57% of voters voted No to Question 4, which would’ve permitted individuals aged 21 and above to use psilocyn, psilocybin, mescaline, ibogaine, and DMT. Eligible persons would’ve also been able to cultivate a personal amount of these psychedelics and been able to help others in those activities. The limits for possession stipulated in the measure were 1g for psilocybin, psilocyn or DMT, 30g for…

WednesdayNov 06, 2024 10:00 am

Could the Nazis, CIA Have Contributed to LSD’s History

LSD was discovered less than a hundred years ago, in 1938 to be precise, by Albert Hofmann. Hofmann, who was a chemist at the time, was working at a Swiss pharmaceutical firm. Its hallucinogenic effects were discovered years later though, in 1943, when the chemist accidentally consumed a small amount. In the 60s, the drug was heralded in hippie counterculture, before being banned with the introduction of the Controlled Substances Act. Did you know that LSD was used by the Nazis as a truth serum, with the CIA also using it in experiments? Following the drug’s discovery, the company Hofmann…

MondayNov 04, 2024 10:00 am

Massachusetts Psychedelic Ballot Measure Elicits Strong Views from Voters

The possible legalization of psychedelics in the state of Massachusetts has garnered a lot of attention, with voters holding different opinions on the drugs and their legalization. Question 4, the ballot measure being voted on in the upcoming November elections, is supported by Massachusetts for Mental Health Options. It outlines a plan to treat individuals aged 21 and above who suffer from severe mental health issues with psychedelics, under the guidance and supervision of a licensed and trained professional at regulated therapy centers. Mass. General Center for Neuroscience of Psychedelics’ director of training and education, Dr. Franklin King, explains that…

WednesdayOct 30, 2024 10:00 am

Researchers Uncover Intriguing Connection Between DMT, Heart Activity

DMT (N,N-Dimethyltryptamine) is a psychedelic known for inducing intense states of consciousness. This psychedelic naturally occurs in different plants and animals, including humans. When consumed, it produces effects that last under 15 minutes, with users often reporting feelings of oneness with the universe, vivid hallucinations, and deep mystical or spiritual experiences. While a lot is known about the psychological effects of psychedelics, not much is known about how the body and its role in these experiences. Now new research has uncovered a new link between patterns of heart activity and mystic experiences induced by DMT. The objective of the investigators…

MondayOct 28, 2024 10:00 am

New Guide to Help Veterans Navigate Psychedelic Treatments Gets Published

A guidebook that may help military veterans explore psychedelic treatments as possible therapies for mental health conditions like post-traumatic stress disorder was recently published. The guide, dubbed The Veteran’s Guide to Psychedelics, was launched on October 22nd. It was developed specifically for veterans by the Heroic Hearts Project, in partnership with Matt Zemon, an author and educator. Zemon explained that the guidebook would help veterans that had turned to psychedelics for healing by assisting them in making informed decisions and empowering them to reclaim control over their emotional and mental health. The guide provides a holistic framework for individuals to…

WednesdayOct 23, 2024 10:00 am

Researchers to Study Psychedelics, Empathogens in Quest for a PTSD Treatment

Post-traumatic stress disorder is a mental health disorder caused by an extremely terrifying or stressful event, either by an individual witnessing it or being a part of it. This disorder may last anywhere between months to years, with individuals experiencing intense physical and emotional reactions when the memories of trauma are unearthed by triggers. Estimates show that in the United Kingdom, 1 in 10 individuals will experience post-traumatic stress disorder in their lifetime. Currently, roughly 30% of patients who suffer from severe mental health conditions find that traditional therapies aren’t effective for them. Now a team of researchers in Cambridgeshire…

TuesdayOct 22, 2024 10:00 am

New Research Explores the Role of Psychedelic Trips in Healing

Interest in psychedelics has increased these last few years after numerous studies found that the drugs may possess therapeutic benefits. For instance, studies have found that ketamine could help reduce symptoms of depression and post-traumatic stress disorder while managing suicidal ideation. Studies also found that psilocybin could help manage symptoms of anxiety and depression, as well as post-traumatic stress disorder. Now new research has investigated the role that psychedelic trips play in healing, with a focus on psilocybin and ketamine. These drugs often induce profound subjective experiences when consumed, with scientists positing that these experiences may contribute to their therapeutic…

ThursdayOct 17, 2024 10:00 am

Producers Are Tweaking Psilocybin Mushrooms to Increase Potency

Research has shown that psychedelics may be useful in the treatment of various mental-health conditions, including post-traumatic stress disorder (PTSD) and depression. Now new methods of cultivation are making hallucinogenic mushrooms stronger, with their effects being felt by users faster and lasting longer. Julian Mattucci, commonly referred to as God Emperor Myco, recently revealed that he had tried about 1.5g of Psilocybe subtropicalis mushrooms. This dosage, which is considerably lower than the amount normally required to have a significant trip, was potent enough to have him lying in bed for three to four hours. Mattucci later tested the mushrooms, discovering…

TuesdayOct 15, 2024 10:00 am

Neuroscience Study Provides Insight into Psilocybin’s Impact on Spatial Awareness

Psilocybin is a psychedelic compound found in hundreds of species of hallucinogenic mushrooms. When ingested, the body converts the compound into psilocin, which is known to act on serotonin 2A receptors in the brain. Numerous studies have shown that psilocybin can alter an individual’s cognition, mood and perception when consumed. Research has also found that the psychedelic may cause profound changes to an individual’s sense of space, self and time. Now new research has looked into how this psychedelic affects activity in the brain and, particularly, its influence on individual neurons. For their research, the investigators studied mice that had…

ThursdayOct 10, 2024 10:00 am

Activists Consider Placing Psychedelic Decriminalization on 2026 State Ballot

Activists in Portland recently revealed that they were working to place a measure to decriminalize psychedelics on the 2026 ballot. The measure in question, called the Portland Psychedelic Health Act, would make the enforcement of laws against specific fungi and plant-based substances, including ayahuasca, psilocybin, DMT and mescaline, a low-enforcement priority in the city. It would also advocate for the decriminalization of psychedelics at the local level while also covering the possession, gifting and cultivation of natural psychedelics. In addition, the measure would establish an advisory panel focused on issuing guidance related to entheogens to the city. According to the…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000